Reducing the cost of covid-19 vaccine is desirable and possible

There was finally light at the end of the covid-19 tunnel in the November 2020 when the world so the emergence of the first vaccines.

with India home to vibrant vaccine industry major vaccine developers contracted Indian vaccine players.

based on the interim result on safety and the efficacy Indian health authorities gave emergency use approval even before large-scale trial completed.

the government ambit on the vaccination programme in the calibrated matter and even roped in the private health care provided by taking upon itself the task supplying dixon black marketing which would otherwise have happened in a grocer supply deficiency situations has been avoided.

India now has to vaccinate a large percentage of the population even at the next wave of infection is looming large the country need about 2 billion roses too hard immunity by vaccinating at least 70% of its 1.39 billion people but current price will cause a huge burden of over 30,000 crore just to procurement of vaccine.

Any reducing cost will not only help the budget of health authority but also be a stimulus to encourage vaccination for that.with only two brands approved for emergency used to date the government had to negotiate prices starting at 200 pados cal ko windshield and 295 ko vaccine the price for both have now been fixed at 150 part doors and additional hundred is compensated to private service provider.

the price of 250 pardos is indeed affordable for those who was to able to private facility even as the job continue to be given 32 public hospital and dispensaries.